miR-124 as a Liquid Biopsy Prognostic Biomarker in Small Extracellular Vesicles from NSCLC Patients

Despite advances in non-small cell lung cancer (NSCLC) research, this is still the most common cancer type that has been diagnosed up to date. microRNAs have emerged as useful clinical biomarkers in both tissue and liquid biopsy. However, there are no reliable predictive biomarkers for clinical use....

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchez-Cabrero, Darío, Garcia-Guede, Álvaro, Burdiel, Miranda, Pernía, Olga, Colmenarejo-Fernandez, Julián, Gutierrez, Laura, Higuera, Oliver, Rodriguez, Isabel Esteban, Rosas-Alonso, Rocío, Rodriguez-Antolín, Carlos, Losantos-García, Itsaso, Vera, Olga, De Castro-Carpeño, Javier, Ibanez de Caceres, Inmaculada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380700/
https://www.ncbi.nlm.nih.gov/pubmed/37511221
http://dx.doi.org/10.3390/ijms241411464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380700/
https://www.ncbi.nlm.nih.gov/pubmed/37511221
http://dx.doi.org/10.3390/ijms241411464

Ejemplares similares